Nigeria has confirmed a case of Ebola in a female traveller who arrived in Abuja from Uganda, prompting health authorities to intensify disease surveillance and contact-tracing efforts to prevent further transmission.
Minister of Health, Muhammad Ali Pate, said laboratory tests confirmed the infection, adding that the patient had been isolated in a hospital in Abuja, where she is receiving medical care.
Health authorities have identified 44 close contacts of the patient and commenced contact-tracing to determine whether others may have been exposed to the virus.
The development makes Nigeria the first West African country to report a case linked to the ongoing Ebola outbreak in East Africa, raising concerns over the potential spread of the disease through international travel.
Travellers have been advised to remain vigilant, monitor their health and seek immediate medical attention if they develop symptoms consistent with Ebola, particularly after visiting countries experiencing active transmission.
The Nigeria Centre for Disease Control and Prevention (NCDC) has intensified surveillance and issued public health guidance for international travellers. Passengers arriving from countries with active or relevant Ebola transmission may be required to complete a health declaration form, while travellers from other countries are currently exempt.
The public has also been advised to avoid contact with the bodily fluids of suspected or confirmed Ebola patients, including blood and vomit, as the virus spreads through direct contact with infected bodily fluids.
Travellers returning from affected countries should promptly inform healthcare providers about their travel history if they develop symptoms such as fever, severe weakness, vomiting or diarrhoea. They should call ahead for medical guidance rather than visiting a healthcare facility without warning, to help prevent possible exposure to others.
Ebola is a rare but potentially fatal viral disease. As the illness progresses, patients may develop vomiting, diarrhoea and organ failure. Some patients also experience internal or external bleeding, although bleeding does not occur in every case.
The current outbreak in the Democratic Republic of Congo, which began in May, has reportedly resulted in at least 4,600 deaths, with more than 9,500 cases recorded, according to the European Centre for Disease Prevention and Control.
The outbreak involves the Bundibugyo species of the Ebola virus, a relatively rare strain for which no approved vaccine or specific treatment is currently available, although clinical trials are under way.
The disease has also been reported in Uganda, where at least two people died, and Kenya, which has recorded at least nine infections. Uganda declared itself free of the disease in August after its last patient was discharged.
On Monday, the United States advised its citizens to reconsider travel to Kenya because of health risks, raising its travel advisory level for the country.
Nigeria successfully contained an Ebola outbreak in 2014, when the disease claimed at least eight lives. The experience demonstrated the importance of rapid detection, effective contact-tracing and strict infection-prevention measures.
With the latest case, health officials face renewed pressure to sustain border surveillance, identify potentially exposed persons quickly and ensure that travellers receive timely information on the risks associated with visiting affected countries.
Travellers are urged to follow official health advisories, cooperate with screening procedures and report suspected symptoms promptly. Early detection, responsible travel and strict adherence to public health guidance remain critical to preventing another outbreak.
